$LGMH Light Media Enters Into Strategic Merger

New Post Public Reply Private Reply Replies (0) Message Board
louied91
240
$LGMH Light Media Enters Into Strategic Merger Agreement

https://www.otcmarkets.com/stock/LGMH/news/Li...?id=445454

ATLANTA, GA, July 1, 2024. GLOBE Newswire -- Light Media Holdings, Inc. (OTC Markets: (LGMH) ("Light Media" today announced that it has entered into a strategic merger agreement with Veri Holdings (VRHI) (Veri Holdings" . Veri Holdings, since 2016, operates as a curator of opportunities, transcending conventional boundaries in healthcare via alternative medicine, telemedicine and artificial intelligence. For more information, visit: www.VeriHoldings.com.

Market Forecasts: Alternative Medicine is projected to experience significant growth, anticipated to escalate from a valuation of USD 143.79 billion in 2023 to nearly USD 1190.19 billion by 2032. Telemedicine Market Size is Expected and Anticipated to Reach USD 869.22 billion by 2033. Artificial intelligence in the healthcare market was valued at USD 16.3 billion in 2022 is expected and anticipated to grow at a CAGR of 40.2% to reach USD 173.55 billion by 2029.

Veri Holdings intends to raise up to $20 million, led by Network 1 Financial Securities, and uplist the company to a higher exchange (e.g. Nasdaq, NYSE). In this regard, Veri Holdings has retained PCAOB registered auditors and reserved stock symbol (VRHI).

The parties anticipate that in connection with the transaction, the shares of Light Media will be combined in a reverse split that is anticipated to range from 1 new share for every existing 20 shares.

The common stock of the combined company will continue to trade on www.OTCMarkets.com. The company will complete a spin-off and name change to reflect its new focus on global opportunities in Telemedicine, Alternative Medicine and Healthcare AI.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Merck & Co., Inc. Investors Urged to Take Action Now

Updated Category News Views 131

Important Notice for Merck & Co., Inc. Investors Investors in Merck & Co., Inc. (MRK) are being encouraged to seek legal counsel as we approach a significant deadline related to a securities class action lawsuit. This timeline marks an important opportunity for purchasers of Merck's securities made between February 3, 2022, and February 3, 2025, to secure representation...

Continue Reading
Justice-Impacted Individuals Gaining Access to Education

Updated Category News Views 116

Expanding Opportunities for Justice-Impacted Individuals In a significant initiative aimed at improving the lives of justice-impacted individuals, multiple states are coming together to enhance educational and workforce pathways. This collaborative effort is focused on providing necessary resources and opportunities for individuals who have faced incarceration, aiming to...

Continue Reading
Celebrating Excellence: 2025 Lifetime Achievement Award Recipients

Updated Category News Views 123

Honoring Peter Murray and SawTeen See at the CTBUH 2025 Awards The Council on Tall Buildings and Urban Habitat (CTBUH) has recognized two remarkable figures in the field of architecture and structural engineering for their essential contributions to urban design. Peter Murray, co-founder of New London Architecture, and SawTeen See, a prominent structural engineer, are the...

Continue Reading
Northern Oil and Gas Expands Horizons with Acquisition Talks

Updated Category News Views 145

Northern Oil and Gas Options for Strategic Growth Northern Oil and Gas is actively pursuing acquisition opportunities, specifically targeting Granite Ridge Resources. Based in Minneapolis, this ambitious company has shown intent to enhance its portfolio by considering Granite Ridge, a relatively smaller player in the oil industry, skilled in extracting resources from...

Continue Reading
Invivyd Announces Insights into VYD2311's Clinical Journey

Updated Category News Views 176

Invivyd Hosts Webcast to Discuss the REVOLUTION Program Invivyd, Inc. (Nasdaq: IVVD) will present a live webcast detailing its innovative REVOLUTION clinical program. This event, aimed at both investors and the public, will showcase the company’s promising monoclonal antibody, VYD2311, which serves as a vaccine alternative for COVID-19 prevention. The Overview of...

Continue Reading